Patents Assigned to Nutragenesis, LLC
  • Patent number: 9393281
    Abstract: Compositions including combinations of ?-glucan and Withania somnifera for increasing the immune activity of certain target cytokines and phagocytosis, and reducing cortisol or corticosterone. Methods of improving immunity activity under periods of stress including chronic stress with a combination of ?-glucan and Withania somnifera are also described. Particular combinations of ?-glucan and Withania somnifera synergistically increases the immune activity of the cytokines IL-12 and IL-6 over expected values.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: July 19, 2016
    Assignees: Nutragenesis, LLC, Natreon, Inc.
    Inventor: Peter S. McNeary
  • Publication number: 20140087009
    Abstract: Compositions including combinations of ?-glucan and Withania somnifera for increasing the immune activity of certain target cytokines and phagocytosis, and reducing cortisol or corticosterone. Methods of improving immunity activity under periods of stress including chronic stress with a combination of ?-glucan and Withania somnifera are also described. Particular combinations of ?-glucan and Withania somnifera synergistically increases the immune activity of the cytokines IL-12 and IL-6 over expected values.
    Type: Application
    Filed: December 2, 2013
    Publication date: March 27, 2014
    Applicant: Nutragenesis, LLC
    Inventor: Peter S. McNeary
  • Patent number: 8597697
    Abstract: Compositions including combinations of ?-glucan and Withania somnifera for increasing the immune activity of certain target cytokines and phagocytosis, and reducing cortisol or corticosterone. Methods of improving immunity activity under periods of stress including chronic stress with a combination of ?-glucan and Withania somnifera are also described. Particular combinations of ?-glucan and Withania somnifera synergistically increases the immune activity of the cytokines IL-12 and IL-6 over expected values.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: December 3, 2013
    Assignee: Nutragenesis, LLC
    Inventor: Peter S. McNeary
  • Publication number: 20120328663
    Abstract: Compositions including combinations of ?-glucan and Withania somnifera for increasing the immune activity of certain target cytokines and phagocytosis, and reducing cortisol or corticosterone. Methods of improving immunity activity under periods of stress including chronic stress with a combination of ?-glucan and Withania somnifera are also described. Particular combinations of ?-glucan and Withania somnifera synergistically increases the immune activity of the cytokines IL-12 and IL-6 over expected values.
    Type: Application
    Filed: June 25, 2012
    Publication date: December 27, 2012
    Applicant: Nutragenesis, LLC
    Inventor: Peter S. McNeary
  • Patent number: 8329231
    Abstract: A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevent free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, and (7) enhance mood.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: December 11, 2012
    Assignee: Nutragenesis, LLC
    Inventor: Peter McNeary
  • Publication number: 20120288574
    Abstract: A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevent free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, and (7) enhance mood.
    Type: Application
    Filed: June 25, 2012
    Publication date: November 15, 2012
    Applicant: Nutragenesis, LLC
    Inventor: Peter McNeary
  • Patent number: 8206757
    Abstract: A therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevents free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, (7) enhance mood.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: June 26, 2012
    Assignees: Nutragenesis, LLC, Natreon, Inc.
    Inventor: Peter McNeary